Currently predicting for Thu, 4 Jun 2026

NKTX Prediction Chart

NKTX Predictions History

Latest community submissions for NKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 4, 2024 Bullish $13.09 V 1
Oct 27, 2023 $2.13 +6.06% $2.05 V 96.01% 1
Oct 27, 2023 $2.09 +3.78% $2.05 V 98.24% 1
Oct 27, 2023 $4.50 +129.59% Unrealistic Excluded from avg $2.05 V 0.00% 1
Jul 17, 2023 $2.09 +4.80% $2.02 V 96.75% 1
Jul 17, 2023 $2.05 +3.00% $2.02 V 98.53% 2
Jul 17, 2023 $2.11 +6.03% $2.02 V 95.54% 1
JS JS Pro
Jun 16, 2023 $5.01 +1.21% $4.87 X 97.13% 0
Jun 16, 2023 $4.84 -2.26% $4.87 V 99.35% 4
Jun 16, 2023 $4.88 -1.41% $4.87 V 99.79% 6
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT NKARTA INC.
Nkarta
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE